Page 2 - Wendy Garrett News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wendy garrett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wendy Garrett Today - Breaking & Trending Today

Food supplement found to alter gut in resolving effects of malnutrition


Food supplement found to alter gut in resolving effects of malnutrition
Research into a food supplement for malnourished children is offering insights into how gut bacteria may affect growth as it appears to ‘repair’ disrupted microbiomes and effectively address the effects of malnutrition.
Writing in the
New England Journal of Medicine, ​a 3-month course of the supplement was enough to increase 21 types of beneficial bacteria numbers as well as a double the growth rate of the children.
Commenting on the proof-of-concept clinical trial, Senior Author Dr Jeffrey Gordon says,
“Malnutrition has proven extraordinarily difficult to treat. ​
“Standard calorie-dense therapeutic foods have been shown to prevent the deaths of malnourished children but have been ineffective in overcoming growth stunting and other damaging effects of malnutrition, including impaired brain development, bone growth and immune function.” ​ ....

Bangladesh General , Robert Chen , Jeffrey Gordon , Wendy Garrett , Harvard Chan School Of Public Health , New England Journal , Senior Author Dr Jeffrey Gordon , Distinguished University Professor , Washington University School , Harvard Chan School , Public Health , பங்களாதேஷ் ஜநரல் , ராபர்ட் சென் , ஜெஃப்ரி கோர்டந் , வெண்டி காரெட் , ஹார்வர்ட் சான் பள்ளி ஆஃப் பொது ஆரோக்கியம் , புதியது இங்கிலாந்து இதழ் , புகழ்பெற்ற பல்கலைக்கழகம் ப்ரொஃபெஸர் , வாஷிங்டன் பல்கலைக்கழகம் பள்ளி , ஹார்வர்ட் சான் பள்ளி , பொது ஆரோக்கியம் ,

Connecting enhancer variants, genes, and disease; synthetic spike binders; measuring tumors' cellular mix; and more


Posted April 9th, 2021 for Broad Institute
Welcome to the April 9, 2021 installment of Research Roundup , a recurring snapshot of recent studies published by scientists at the Broad Institute and their collaborators.
Enhancing V2F maps
GWASs have yielded thousands of genetic variants linked to disease. To help figure out the function of many of these variants, Joseph Nasser (now at Caltech), Drew Bergman, Charles Fulco (now at Bristol Myers Squibb), Philine Guckelberger (now at the Free University of Berlin), Benjamin Doughty (now at Stanford University), Eric Lander (on leave), Jesse Engreitz (now at Stanford), and colleagues used their activity-by-contact (ABC) model to build maps that connect enhancers to their target genes in 131 cell types and tissues. Using those maps, the team linked more than 5,000 GWAS signals to nearly 2,250 genes across 72 traits and diseases. The researchers also predicted which enhancers contain risk variants for inflammat ....

Joseph Nasser , Wendy Garrett , Harvard Chan Microbiome , Curtis Huttenhower , Stefan Dentro , Guoping Feng , Ben Deverman , Kerstin Haase , Bradley Pentelute , Amit Deshwar , Eric Lander , Ignaty Leshchiner , Philine Guckelberger , Benjamin Doughty , Maxime Tarabichi , David Liu , Yulia Rubanova , Jesse Engreitz , Jeff Wintersinger , Charles Fulco , Jonas Demeulemeester , Broad Institute , Geoff Macintyre University Of Cambridge , Somatic Cell Genome Editing Consortium , Public Health Center , Stanley Center ,

Senda Biosciences Announces Formation of World-Class Scientific Advisory Board


Share this article
Share this article
CAMBRIDGE, Mass., Jan. 7, 2021 /PRNewswire/ Senda Biosciences, a Flagship Pioneering company creating novel categories of medicines based on Intersystems Biology, today announced the formation of its Scientific Advisory Board (SAB). Senda s SAB is composed of leading experts across immunology, microbiology, biochemistry, and neurology, and will collaborate with Senda s leadership to support and advance the new research discipline of Intersystems Biology. This discipline focuses on how molecular connections among botanical, bacterial, and human cells coevolved over millennia define health and disease.
We are thrilled to have attracted some of the brightest minds in their fields to our SAB, says Guillaume Pfefer, PhD, chief executive officer of Senda. The deep expertise of the SAB will be pivotal to the advancement of our novel approach to medicines development, rooted in an unparalleled understanding of interspecies molecular c ....

United States , Dana Farber Cancer Institute , California Institute Of Technology , United Kingdom , University Of California San Diego , Steve Jacobsen , Roger Innes , Wendy Garrett , Ramnik Xavier , Los Angeles , Prnewswire Senda Biosciences , Guillaume Pfefer , Randy Schekman , James Rothman , Senda Biosciences , Wendys Garrett , Luke Oneill , Vijay Kuchroo , Royal Society , University Of Colorado Boulder , Trinity College Dublin , Inflammation Research Group , International Cytokine , University Of Cambridge , Immunologic Diseases At Harvard Medical School , American Association For The Advancement Of Science ,